These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2704029)

  • 21. Inhibition of rat liver and duodenum soluble catechol-O-methyltransferase by a tight-binding inhibitor OR-462.
    Schultz E; Nissinen E
    Biochem Pharmacol; 1989 Nov; 38(22):3953-6. PubMed ID: 2597177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of a novel series of "ortho-nitrated" inhibitors of catechol-O-methyltransferase.
    Learmonth DA; Bonifácio MJ; Soares-da-Silva P
    J Med Chem; 2005 Dec; 48(25):8070-8. PubMed ID: 16335931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of bifunctional nitrocatechol inhibitors of pig liver catechol-O-methyltransferase.
    Bailey K; Tan EW
    Bioorg Med Chem; 2005 Oct; 13(20):5740-9. PubMed ID: 16002297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular modeling and metabolic studies of the interaction of catechol-O-methyltransferase and a new nitrocatechol inhibitor.
    Palma PN; Bonifácio MJ; Loureiro AI; Wright LC; Learmonth DA; Soares-da-Silva P
    Drug Metab Dispos; 2003 Mar; 31(3):250-8. PubMed ID: 12584150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A comparison of 2-hydroxyestradiol and U-0521 (3'4'-dihydroxy-2-methylpropiophenone, Upjohn) as in situ and in vitro inhibitors of tyrosine hydroxylase.
    Lloyd T; Boyd B; Walega MA; Ebersole BJ; Weisz J
    J Neurochem; 1982 Apr; 38(4):948-54. PubMed ID: 6121005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism.
    Brannan T; Prikhojan A; Yahr MD
    J Neural Transm (Vienna); 1997; 104(1):77-87. PubMed ID: 9085195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. D1-like dopamine receptor activation and natriuresis by nitrocatechol COMT inhibitors.
    Vieira-Coelho MA; Gomes P; Serrão MP; Soares-da-Silva P
    Kidney Int; 2001 May; 59(5):1683-94. PubMed ID: 11318939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catechol O-methyltransferase. 11. Inactivation by 5-hydroxy-3-mercapto-4-methoxybenzoic acid.
    Borchardt RT; Huber JA
    J Med Chem; 1982 Mar; 25(3):321-3. PubMed ID: 7069707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A structure-activity relationship study of catechol-O-methyltransferase inhibitors combining molecular docking and 3D QSAR methods.
    Tervo AJ; Nyrönen TH; Rönkkö T; Poso A
    J Comput Aided Mol Des; 2003 Dec; 17(12):797-810. PubMed ID: 15124929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and optimization of N-heterocyclic pyridinones as catechol-O-methyltransferase (COMT) inhibitors.
    Zhao Z; Harrison ST; Schubert JW; Sanders JM; Polsky-Fisher S; Zhang NR; McLoughlin D; Gibson CR; Robinson RG; Sachs NA; Kandebo M; Yao L; Smith SM; Hutson PH; Wolkenberg SE; Barrow JC
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2952-2956. PubMed ID: 27133481
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of 3',4'-dihydroxy-2-methyl-propriophenone (U-0521) on catechol-O-methyltransferase activity and on DOPA accumulation in rat red blood cells and corpus striatum.
    Reches A; Jiang D; Fahn S
    Biochem Pharmacol; 1982 Nov; 31(21):3415-8. PubMed ID: 7150363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Catechol O-methyltransferase. 10. 5-Substituted 3-hydroxy-4-methoxybenzoic acids (isovanillic acids) and 5-substituted 3-hydroxy-4-methoxybenzaldehydes (isovanillins) as potential inhibitors.
    Borchardt RT; Huber JA; Houston M
    J Med Chem; 1982 Mar; 25(3):258-63. PubMed ID: 7069704
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Catechol-O-methyltransferase.
    Flohé L
    Int Pharmacopsychiatry; 1974; 9(1):52-60. PubMed ID: 4599326
    [No Abstract]   [Full Text] [Related]  

  • 34. No change of brain extracellular catecholamine levels after acute catechol-O-methyltransferase inhibition: a microdialysis study in anaesthetized rats.
    Li YH; Wirth T; Huotari M; Laitinen K; MacDonald E; Männistö PT
    Eur J Pharmacol; 1998 Sep; 356(2-3):127-37. PubMed ID: 9774242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of entacapone on colon motility and ion transport in a rat model of Parkinson's disease.
    Li LS; Liu CZ; Xu JD; Zheng LF; Feng XY; Zhang Y; Zhu JX
    World J Gastroenterol; 2015 Mar; 21(12):3509-18. PubMed ID: 25834315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enantioselectivity in the methylation of the catecholic phase I metabolites of methylenedioxy designer drugs and their capability to inhibit catechol-O-methyltransferase-catalyzed dopamine 3-methylation.
    Meyer MR; Maurer HH
    Chem Res Toxicol; 2009 Jun; 22(6):1205-11. PubMed ID: 19462939
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medicinal chemistry of catechol O-methyltransferase (COMT) inhibitors and their therapeutic utility.
    Kiss LE; Soares-da-Silva P
    J Med Chem; 2014 Nov; 57(21):8692-717. PubMed ID: 25080080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of human catechol-O-methyltransferase-mediated dopamine O-methylation by daphnetin and its Phase II metabolites.
    Liang SC; Ge GB; Xia YL; Pei-Pei D; Ping W; Qi XY; Cai-Xia T; Ling Y
    Xenobiotica; 2017 Jun; 47(6):498-504. PubMed ID: 27435571
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of catechol-O-methyltransferase by 1-vinyl derivatives of nitrocatechols and nitroguaiacols. Kinetics of the irreversible inhibition by 3-(3-hydroxy-4-methoxy-5-nitro benzylidene)-2,4-pentanedione.
    Pérez RA; Fernández-Alvarez E; Nieto O; Piedrafita FJ
    Biochem Pharmacol; 1993 May; 45(10):1973-81. PubMed ID: 8512582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological profile of opicapone, a third-generation nitrocatechol catechol-O-methyl transferase inhibitor, in the rat.
    Bonifácio MJ; Torrão L; Loureiro AI; Palma PN; Wright LC; Soares-da-Silva P
    Br J Pharmacol; 2015 Apr; 172(7):1739-52. PubMed ID: 25409768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.